These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19406979)

  • 21. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
    Zhang Y; Wang HB; Chi LJ; Wang WZ
    Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
    Wan Q; Liu Z; Yang M; Wu J
    Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nilotinib on regulatory T cells: the dose matters.
    Fei F; Yu Y; Schmitt A; Rojewski MT; Chen B; Greiner J; Götz M; Bunjes D; Schmitt M
    Mol Cancer; 2010 Jan; 9():22. PubMed ID: 20113470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
    Chu ZQ; Ji Q
    Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells.
    Cao M; Cabrera R; Xu Y; Liu C; Nelson D
    Cell Biol Int; 2009 May; 33(5):565-71. PubMed ID: 19268553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of hemodialysis on circulating CD4(low)CD25 (high) regulatory T cells in end-stage renal disease patients.
    Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Bryl E; Witkowski JM
    Inflamm Res; 2014 Feb; 63(2):99-103. PubMed ID: 24189710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T-Cells Mediate IFN-α-Induced Resistance against Antigen-Induced Arthritis.
    Chenna Narendra S; Chalise JP; Biggs S; Kalinke U; Magnusson M
    Front Immunol; 2018; 9():285. PubMed ID: 29515584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.
    Baraut J; Grigore EI; Jean-Louis F; Khelifa SH; Durand C; Verrecchia F; Farge D; Michel L
    Bone Marrow Transplant; 2014 Mar; 49(3):349-54. PubMed ID: 24362364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of up-regulating CD4(+)CD25(+) Tregs by IFN-γ in myasthenia gravis patients.
    Huang S; Wang W; Chi L
    BMC Neurol; 2015 Sep; 15():163. PubMed ID: 26347149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+CD25+Foxp3+ regulatory T cells protect endothelial function impaired by oxidized low density lipoprotein via the KLF-2 transcription factor.
    Li M; Wang X; Fu W; He S; Li D; Ke Q
    Cell Physiol Biochem; 2011; 28(4):639-48. PubMed ID: 22178876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.
    Fei F; Yu Y; Schmitt A; Rojewski MT; Chen B; Götz M; Döhner H; Bunjes D; Schmitt M
    Br J Haematol; 2009 Jan; 144(2):195-205. PubMed ID: 19016717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4
    Ge Y; Huang M; Wu Y; Dong N; Yao YM
    J Cell Mol Med; 2020 Jan; 24(2):2027-2039. PubMed ID: 31880383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
    Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
    Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.